The total return over the past 12 months is -68.76% vs. +16.94% for the S&P 500. So far it's up -75.38% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (68.76%) | (63.59%) | (69.13%) | (50.22%) | (35.86%) | (29.14%) |
| Total Return CAGR | (68.76%) | (63.59%) | (69.13%) | (50.22%) | (35.86%) | (29.14%) |
| Revenue CAGR | (50.00%) | (89.91%) | N/A | (54.25%) | (25.86%) | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Alaunos Therapeutics, Inc. (TCRT)
| Year | Start price | End price | TCRT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.23 | $0.80 | (75.38%) | +14.51% | (89.89%) |
| 2025 | $1.91 | $3.23 | +69.11% | +17.72% | +51.39% |
| 2024 | $10.61 | $1.91 | (82.00%) | +24.89% | (106.89%) |
| 2023 | $97.37 | $10.61 | (89.10%) | +26.19% | (115.29%) |
| 2022 | $163.50 | $97.37 | (40.45%) | (18.17%) | (22.28%) |
| 2021 | $378.00 | $163.50 | (56.75%) | +28.74% | (85.49%) |
| 2020 | $708.00 | $378.00 | (46.61%) | +18.37% | (64.98%) |
| 2019 | $280.50 | $708.00 | +152.41% | +31.22% | +121.19% |
| 2018 | $621.00 | $280.50 | (54.83%) | (4.56%) | (50.27%) |
| 2017 | $802.50 | $621.00 | (22.62%) | +21.70% | (44.32%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
